Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2D6 | P10635 | 6/20 | 0.80 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.80 |
| ▸ | CYP2C19 | P33261 | 3/20 | 0.68 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.68 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.68 |
| ▸ | TSHR | P16473 | 1/20 | 0.68 |
| ▸ | MEN1 | O00255 | 2/20 | 0.68 |
| ▸ | F3 | P13726 | 4/20 | 0.54 |
| ▸ | DRD1 | P21728 | 3/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.52 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.46 |
| ▸ | BCHE | P06276 | 1/20 | 0.44 |
| ▸ | MAPT | P10636 | 1/20 | 0.43 |
| ▸ | TUBB4A | P04350 | 1/20 | 0.42 |
| ▸ | TUBB | P07437 | 1/20 | 0.42 |
| ▸ | TUBA3C | P0DPH7 | 1/20 | 0.42 |
| ▸ | TUBA1B | P68363 | 1/20 | 0.42 |
| ▸ | TUBA4A | P68366 | 1/20 | 0.42 |
| ▸ | TUBB4B | P68371 | 1/20 | 0.42 |
| ▸ | TUBB3 | Q13509 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Allocryptopine SCHEMBL29568468 | 0.89 | CYP2D6 (1.00) | CYP2D6KMT2ACYP2C19KDM4ECYP3A4 | |
| Allocryptopine SCHEMBL673252 | 0.89 | CYP2D6 (1.00) | CYP2D6KMT2ACYP2C19KDM4ECYP3A4 | |
| Allocryptopine SCHEMBL30477770 | 0.89 | CYP2D6 (1.00) | CYP2D6KMT2ACYP2C19KDM4ECYP3A4 | |
| SCHEMBL9882661 | 0.84 | CYP2D6 (0.71) | CYP2D6KMT2ACYP2C19KDM4ECYP3A4 | |
| SCHEMBL11891038 | 0.82 | CYP2D6 (0.77) | CYP2D6KMT2ACYP2C19KDM4ECYP3A4 | |
| SCHEMBL16970984 | 0.82 | CYP2D6 (0.84) | CYP2D6KMT2ACYP2C19KDM4ECYP3A4 | |
| SCHEMBL178013 | 0.81 | CYP2D6 (1.00) | CYP2D6KMT2ACYP2C19KDM4ECYP3A4 | |
| SCHEMBL29356135 | 0.81 | CYP2D6 (1.00) | CYP2D6KMT2ACYP2C19KDM4ECYP3A4 | |
| SCHEMBL178039 | 0.81 | KMT2A (1.00) | CYP2D6KMT2ACYP2C19KDM4ECYP3A4 | |
| SCHEMBL29419477 | 0.81 | KMT2A (1.00) | CYP2D6KMT2ACYP2C19KDM4ECYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230172916-A1 | COMPOSITION COMPRISING AT LEAST ONE PROTOBERBERINE ALKALOID AND METHOD FOR MANUFACTURING SAME | ELEONOR (BE) | 2023-06-08 | — | — | US | claimed |
| EP-4135666-A1 | COMPOSITION COMPRISING AT LEAST ONE PROTOBERBERINE ALKALOID AND METHOD FOR MANUFACTURING SAME | Eleonor (BE) | 2023-02-22 | — | — | EP | claimed |
| WO-2021209623-A1 | COMPOSITION COMPRISING AT LEAST ONE PROTOBERBERINE ALKALOID AND METHOD FOR MANUFACTURING SAME | ELEONOR SPRL (BE) | 2021-10-21 | — | — | WO | claimed |
| EP-3672575-A1 | COMPOSITION COMPRISING AT LEAST ONE PROTOBERBERINE ALKALOID AND ITS PRODUCTION PROCESS | Eleonor SPRL (BE) | 2020-07-01 | — | — | EP | claimed |
| WO-2019038430-A1 | COMPOSITION COMPRISING AT LEAST ONE PROTOBERBERINE ALKALOID AND ITS PRODUCTION PROCESS | ELEONOR SPRL (BE) | 2019-02-28 | — | — | WO | claimed |
| US-20230172916-A1 | COMPOSITION COMPRISING AT LEAST ONE PROTOBERBERINE ALKALOID AND METHOD FOR MANUFACTURING SAME | ELEONOR (BE) | 2023-06-08 | — | — | US | disclosed |
| EP-4135666-A1 | COMPOSITION COMPRISING AT LEAST ONE PROTOBERBERINE ALKALOID AND METHOD FOR MANUFACTURING SAME | Eleonor (BE) | 2023-02-22 | — | — | EP | disclosed |
| WO-2021209623-A1 | COMPOSITION COMPRISING AT LEAST ONE PROTOBERBERINE ALKALOID AND METHOD FOR MANUFACTURING SAME | ELEONOR SPRL (BE) | 2021-10-21 | — | — | WO | disclosed |
| EP-3672575-A1 | COMPOSITION COMPRISING AT LEAST ONE PROTOBERBERINE ALKALOID AND ITS PRODUCTION PROCESS | Eleonor SPRL (BE) | 2020-07-01 | — | — | EP | disclosed |
| WO-2019038430-A1 | COMPOSITION COMPRISING AT LEAST ONE PROTOBERBERINE ALKALOID AND ITS PRODUCTION PROCESS | ELEONOR SPRL (BE) | 2019-02-28 | — | — | WO | disclosed |
| EP-1644012-B1 | QUATERNARY CHELIDONINE AND ALKALOID DERIVATIVES, PROCESS FOR THEIR PREPARATION AND THEIR USE IN THE PREPARATION OF MEDICAMENTS | NOWICKY WASSILI (AT) | 2010-06-02 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230172916-A1 | COMPOSITION COMPRISING AT LEAST ONE PROTOBERBERINE ALKALOID AND METHOD FOR MANUFACTURING SAME | MANBA, CROCC, MAN2A1 | CYP2D6 2517/4885KMT2A 4434/4885CYP2C19 3913/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.